Submissions invited on Automated Whole Brain Tractography from April 5 to August 20, 2017
Synaptive Medical Inc. has partnered with the Cureus Journal of Medical Science, a peer-reviewed publication indexed with PubMed Central, to foster deeper research discussions about Automated Whole-Brain Tractography.
Through the partnership, Cureus has launched the Automated Whole Brain Tractography: Clinical Impact in Neurosurgery publishing competition. Cureus will solely administer the academic competition, which runs from April 5 until submissions close August 2, 2017. Winners will be announced September 20, 2017.
“Preserving eloquent brain is foundational to neurosurgery,” said Dr. John R. Adler, CEO of Cureus and professor of neurosurgery at Stanford University. “Over the past decade, Diffusion Tensor Imaging (DTI) has become an important tool for the pre-, intra-, and post-operative visualization of white matter tracts, thereby enabling neurosurgeons to maximally preserve neurologic function. Recent software advances in Automated Whole Brain Tractography now provide a more intuitive and easy-to-use vehicle for visualizing whole brain tractography in surgical patients. This competition looks to showcase practical neurosurgical opportunities stemming from such contemporary software tools. We look forward to receiving a wide variety of compelling manuscripts.”
Article submission, review, and publication is entirely free. To encourage knowledge sharing and cross-discipline awareness, full-article access for all published materials will also be free.
Three Cureus Scientific Excellence™ prizes totaling $9,500 USD will be awarded to the published articles deemed to be of the highest scientific interest and impact, as determined via crowdsourced voting from the global neurosurgery and clinical community.
Eligible manuscript types include case reports, case series, technical reports, or review articles. An independent peer-review panel of experts will adjudicate all submissions and reward the most noteworthy work.
The independent peer-review panel includes:
“As a company, Synaptive is deeply committed to fostering research cultures,” said Cameron Piron, President and Co-Founder at Synaptive Medical Inc. “Sponsoring a Cureus competition presents clinicians and researchers working with tractography with a new forum to feature their work. It’s an exciting opportunity to showcase the depth of activity around this research topic while highlighting its clinical value to the wider field of neuroscience.”
Additional competition details:
More details about the competition, including ethics compliance and Sunshine Act reporting, are available on Cureus’ website.
About Cureus
The Cureus Journal of Medical Science is a no-cost, peer-reviewed online medical publishing platform leveraging a unique crowdsourced post-publication review process. Relying on the collective intelligence of its clinical community, Cureus enables faster publication, greater access, and ultimately, better research. Visit http://www.cureus.com for more information.
About Synaptive
Synaptive Medical Inc., a Toronto-based medical device and technology company, collaborates with leading clinicians and healthcare systems to revolutionize products and services that cross traditional barriers to enable continuous improvement in care delivery in and beyond the operating room. Synaptive’s integrated BrightMatter™ solutions — including surgical planning, navigation and visualization, and an informatics platform — are designed to give clinicians the right information they need to ensure the best possible outcomes for patients.
Cureus Contact:
Mark Arnold
mark.arnold@cureus.com
+1-415-533-4743
Synaptive Contact:
Elizabeth Monier-Williams
elizabeth.monierwilliams@synaptivemedical.com
+1-647-925-3435 x169